Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_assertion description "[The association of interleukin-1beta (IL-1B) -511C > T and IL-1 receptor antagonist (IL-1RN) VNTR, transforming growth factor-beta (TGF-B1) +28C > T and interferon-gamma (IFN-G) + 874T>A polymorphisms with bladder cancer (CaB) susceptibility and risk of recurrence in Bacillus Calmette-Gu�rin (BCG)-treated patients was analyzed in 287 controls and 213 CaB patients (73 BCG treated).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_assertion evidence source_evidence_literature NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_assertion SIO_000772 19489682 NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_assertion wasDerivedFrom befree-20150227 NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_assertion wasGeneratedBy ECO_0000203 NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP488375.RAK6OhSRW9R7CwNRPIwtCv9hAJIuglVN3uh64O1TofnSA130_provenance.